AZD7442

AstraZeneca antibody cocktail succeeds in study to treat COVID-19

AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in… Read More

AstraZeneca seeks authorisation of drug to prevent COVID-19

AstraZeneca has requested emergency use authorisation from US regulators for its new treatment to prevent… Read More

AstraZeneca says antibody treatment failed in preventing COVID-19

AZD7442 reduced the risk of developing symptomatic COVID-19 by 33% compared to a placebo, which… Read More